ReviewInternational journal of nanomedicine2026
Innovative Strategies of Nanocapsules for Maximizing Efficacy in Tumor Immunotherapy.
Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review explores nanocapsules as a versatile platform to overcome the limitations of drug resistance inherent in conventional cancer therapy and immunotherapy. These nanosystems are capable of enhancing drug delivery, facilitating immune activation and modulating the tumor microenvironment. The review systematically classifies nanocapsules into distinct categories, including bacterial carriers, protein frameworks, lipids, metals, inorganic non-metals and polymers. Key findings demonstrate that nanocapsules possess the capacities for targeted delivery, stimuli-responsive release and synergistic combination with chemotherapy, radiotherapy, as well as photodynamic/photothermal therapy. However, several hurdles remain for their clinical translation, namely insufficient clinical trials and challenges in production scalability. In addition, the review discusses the impacts of different physical properties of nanocapsules and the underlying mechanisms of drug resistance. By uniquely integrating the classification of nanocapsules with corresponding therapeutic strategies, this review provides valuable insights for improving the efficacy of tumor immunotherapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.